Meet Josette Landry: Founder of Streamline Genomics

Josette is the CEO and founder of Streamline Genomics and visiting scholar at the Faculty of Medicine, Université de Montréal. Prior to launching Streamline, she was VP, Business Development for Mitacs, a research organization where she helped facilitate partnerships between university researchers and industry. During her graduate studies, Josette co-founded a consulting firm providing bioinformatics services to the Vancouver biotechnology sector. She received her Ph.D. in Genetics from the Terry Fox Labs at the UBC in 2003, followed by a PDF at the University of Cambridge. Dr Landry also holds an MBA from HEC Montréal.

I chose my career path because… I wish I could say there had been a plan.  I have so far followed my interests in both science and business.

My proudest accomplishment is… Completing my MBA while I was juggling a demanding career and my kids were little.  I’m very thankful to my family and spouse for supporting (my sometimes) crazy goals.

My boldest move to date was… Leaving an executive position to start a company.

I surprise people when I tell them… I do not like to speak in public and I’m actually quite uncomfortable being on a stage.

My best advice to people starting their career is… To get involved in different initiatives and demonstrate leadership!

My best advice from a mentor was…Do not get stuck in the weeds/dwell on the small stuff (ne pas s’enfarger dans les fleurs du tapis).

I would tell young girls thinking about a career in STEM… To go for it!

My biggest setback was… My mom’s breast cancer diagnosis two years ago.

I overcame it by… Turning this personal challenge into an opportunity to raise funding for cancer research and the motivation to launch a start-up.

If I were to pick one thing that has helped me succeed, it would be… The incredible support I have had from family & friends.

If you googled me, you still wouldn’t know… That I despise cilantro.

I stay inspired by… Our mission at Streamline Genomics, which is to democratize genomics analysis so that more patients can benefit from personalized medicine.